Interventional Cardiology News and Research

RSS

Study: One in four early cardiogenic shock patients experience worse outcomes

In one of the largest studies of early cardiogenic shock (CS) patients, where blood flow is still functioning to vital organs, researchers demonstrated that 26% experienced worse outcomes, including care escalation, CS deterioration, or in-hospital mortality.

2 May 2025

Electronic alerts could improve survival for patients with severe aortic stenosis

A new method of alerting clinical care providers holds promise for increasing treatment and improving survival for patients with severe aortic stenosis (AS), a valvular heart condition that can be deadly when left untreated.

23 Apr 2025

Mount Sinai Fuster Heart Hospital earns national recognition for patient care excellence

The Mount Sinai Fuster Heart Hospital's cardiology faculty practice has received the 2024 Human Experience Pinnacle of Excellence Award from Press Ganey, one of the nation's leading patient experience organizations.

16 Apr 2025

FAME-3 study reveals similar outcomes for CABG and PCI in severe triple-vessel heart disease

In sharp contrast to earlier studies, patients with severe triple-vessel heart disease fared equally well whether they underwent open-heart bypass surgery (CABG) or a less invasive procedure called PCI (percutaneous coronary intervention) at five years of follow-up, according to research presented at the American College of Cardiology's Annual Scientific Session.

31 Mar 2025

Urgent call for better safety measures in cardiac catheterization labs

A survey conducted by the Society for Cardiovascular Angiography and Interventions (SCAI) highlights ongoing radiation and orthopedic hazards faced by interventional cardiologists and cardiac catheterization laboratory ("cath lab" or CCL) staff.

4 Mar 2025

Type 1 diabetes patients face lower cardiovascular risk than Type 2 diabetes

A new study published in JSCAI has revealed a lower risk of cardiovascular events for patients with Type 1 diabetes (often called juvenile diabetes) compared to those with Type 2 diabetes.

12 Feb 2025

Boston Scientific announces agreement to acquire Bolt Medical, Inc.

Boston Scientific Corporation today announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced laser-based platform for the treatment of coronary and peripheral artery disease.

From Boston Scientific 13 Jan 2025

Cardiac damage framework may identify patients who could benefit from earlier TAVR

Findings from the TAVR UNLOAD study found limited benefits of transcatheter aortic valve replacement (TAVR) in the treatment of heart failure (HF) with reduced ejection fraction (HFrEF) and moderate aortic stenosis (AS).

29 Oct 2024

NYU Langone Health sets benchmark for heart attack survival rates

NYU Langone Health has the lowest heart attack mortality rate in the country, according to the latest data from the Centers for Medicare and Medicaid Services (CMS).

28 Oct 2024

SCAI publishes comprehensive guidelines for STEMI treatment

The Society for Cardiovascular Angiography & Interventions (SCAI) is pleased to announce the publication of the Expert Consensus Statement on the Management of Patients with STEMI Referred for Primary PCI.

12 Oct 2024

New study confirms safety of SGLT2 inhibitors after acute myocardial infarction

The SGLT2 inhibitor empagliflozin confers kidney-protective benefits and can therefore be given safely and effectively to patients when they are hospitalized for acute myocardial infarction (MI), a Mount Sinai-led global team of researchers has shown.

1 Sep 2024

TCT 2024 to feature latest advances in interventional cardiovascular medicine

The Cardiovascular Research Foundation is pleased to announce the late-breaking clinical trials and science to be featured at TCT 2024.

28 Aug 2024

From Dr. Oz to heart valves: A tiny device charted a contentious path through the FDA

In 2013, the FDA approved an implantable device to treat leaky heart valves. Among its inventors was Mehmet Oz, the former television personality and former U.S. Senate candidate widely known as "Dr. Oz."

9 Jul 2024

Combined use of popular diabetes drugs likely to offer additional protection against heart and kidney disease

New research shows combined use of sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP1-RAs) is likely to offer additional protection against heart and kidney disease in patients with diabetes.

8 Jul 2024

Study shows comparable outcomes for TAVR and SAVR in aortic valve replacement

A new study demonstrated parity between a minimally invasive procedure to replace the aortic valve in the heart - transcatheter aortic valve replacement (TAVR) - and surgical aortic valve replacement (SAVR).

15 May 2024

New data reveals optimal timing for percutaneous coronary intervention in TAVR patients

New data reveals that percutaneous coronary intervention (PCI) can be safely performed before, during, or after transcatheter aortic valve replacement (TAVR) for patients with stable coronary artery disease (CAD).

3 May 2024

Analysis shows gender and racial disparities in pulmonary embolism treatment

New data from the REAL-PE analysis investigated catheter-based pulmonary embolism (PE) treatment, showing women and Black people were less frequently treated with minimally invasive therapy compared to men or non-Black patients.

3 May 2024

New studies underscore the importance of inclusive approaches in peripheral artery disease treatment

New clinical results highlight the need for inclusive approaches and comprehensive examinations of treatment options for peripheral artery disease (PAD), including endovascular therapy and revascularization.

3 May 2024

SMART study shows hemodynamic benefits of self-expanding valves in aortic stenosis patients

Additional analysis from the SMall Annuli Randomized To Evolut or SAPIEN (SMART) study demonstrated clinical non-inferiority of self-expanding valves (SEV) versus balloon-expandable valves (BEV) in aortic stenosis patients undergoing transcatheter aortic valve replacement (TAVR) and confirmed valve performance superiority over time based on hemodynamics.

3 May 2024

Novel dual-action thrombectomy device shows promise in treating acute pulmonary embolism

Late-breaking data from the ENGULF trial showed that a novel dual-action thrombectomy device was effective and safe in treating acute pulmonary embolism (PE).

3 May 2024

Interventional Cardiology News and Research

Study: One in four early cardiogenic shock patients experience worse outcomes

Electronic alerts could improve survival for patients with severe aortic stenosis

Mount Sinai Fuster Heart Hospital earns national recognition for patient care excellence

FAME-3 study reveals similar outcomes for CABG and PCI in severe triple-vessel heart disease

Urgent call for better safety measures in cardiac catheterization labs

Type 1 diabetes patients face lower cardiovascular risk than Type 2 diabetes

Boston Scientific announces agreement to acquire Bolt Medical, Inc.

Cardiac damage framework may identify patients who could benefit from earlier TAVR

NYU Langone Health sets benchmark for heart attack survival rates

SCAI publishes comprehensive guidelines for STEMI treatment

New study confirms safety of SGLT2 inhibitors after acute myocardial infarction

TCT 2024 to feature latest advances in interventional cardiovascular medicine

From Dr. Oz to heart valves: A tiny device charted a contentious path through the FDA

Combined use of popular diabetes drugs likely to offer additional protection against heart and kidney disease

Study shows comparable outcomes for TAVR and SAVR in aortic valve replacement

New data reveals optimal timing for percutaneous coronary intervention in TAVR patients

Analysis shows gender and racial disparities in pulmonary embolism treatment

New studies underscore the importance of inclusive approaches in peripheral artery disease treatment

SMART study shows hemodynamic benefits of self-expanding valves in aortic stenosis patients

Novel dual-action thrombectomy device shows promise in treating acute pulmonary embolism

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News